RESUMO
The p33ING1 protein is a regulator of cell cycle, senescence, and apoptosis. Three alternatively spliced transcripts of p33ING1 encode p47ING1a, p33ING1b, and p24ING1c. We cloned an additional ING family member, p33ING2/ING1L. Unlike p33ING1b, p33ING2 is induced by the DNA-damaging agents etoposide and neocarzinostatin. p33ING1b and p33ING2 negatively regulate cell growth and survival in a p53-dependent manner through induction of G(1)-phase cell-cycle arrest and apoptosis. p33ING2 strongly enhances the transcriptional-transactivation activity of p53. Furthermore, p33ING2 expression increases the acetylation of p53 at Lys-382. Taken together, p33ING2 is a DNA damage-inducible gene that negatively regulates cell proliferation through activation of p53 by enhancing its acetylation.
Assuntos
Apoptose/fisiologia , Dano ao DNA , Proteínas de Homeodomínio/fisiologia , Processamento de Proteína Pós-Traducional , Proteína Supressora de Tumor p53/metabolismo , Proteínas Supressoras de Tumor , Acetilação , Sequência de Aminoácidos , Apoptose/efeitos dos fármacos , Bleomicina/farmacologia , Divisão Celular , Células Cultivadas/efeitos dos fármacos , Células Cultivadas/efeitos da radiação , Cisplatino/farmacologia , Clonagem Molecular , Doxorrubicina/farmacologia , Etoposídeo/farmacologia , Fase G1 , Raios gama , Regulação da Expressão Gênica/efeitos dos fármacos , Proteínas de Homeodomínio/genética , Proteínas de Homeodomínio/isolamento & purificação , Humanos , Dados de Sequência Molecular , Receptores Citoplasmáticos e Nucleares , Transcrição Gênica , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/efeitos da radiação , Ensaio Tumoral de Célula-Tronco , Zinostatina/farmacologiaRESUMO
Breast cancer is a chief cause of cancer-related mortality that affects women worldwide. About 8% of cases are hereditary, and approximately half of these are associated with germline mutations of the breast tumor suppressor gene BRCA1 (refs. 1,2). We have previously reported a mouse model in which Brca1 exon 11 is eliminated in mammary epithelial cells through Cre-mediated excision. This mutation is often accompanied by alterations in transformation-related protein 53 (Trp53, encoding p53), which substantially accelerates mammary tumor formation. Here, we sought to elucidate the underlying mechanism(s) using mice deficient in the Brca1 exon 11 isoform (Brca1Delta11/Delta11). Brca1Delta11/Delta11 embryos died late in gestation because of widespread apoptosis. Unexpectedly, elimination of one Trp53 allele completely rescues this embryonic lethality and restores normal mammary gland development. However, most female Brca1Delta11/Delta11 Trp53+/- mice develop mammary tumors with loss of the remaining Trp53 allele within 6-12 months. Lymphoma and ovarian tumors also occur at lower frequencies. Heterozygous mutation of Trp53 decreases p53 and results in attenuated apoptosis and G1-S checkpoint control, allowing Brca1Delta11/Delta11 cells to proliferate. The p53 protein regulates Brca1 transcription both in vitro and in vivo, and Brca1 participates in p53 accumulation after gamma-irradiation through regulation of its phosphorylation and Mdm2 expression. These findings provide a mechanism for BRCA1-associated breast carcinogenesis.
Assuntos
Apoptose/genética , Ciclo Celular/genética , Transformação Celular Neoplásica/genética , Genes BRCA1 , Genes p53 , Neoplasias Mamárias Animais/genética , Animais , Éxons , Feminino , Genes Letais , Linfoma/etiologia , Linfoma/genética , Glândulas Mamárias Animais/crescimento & desenvolvimento , Neoplasias Mamárias Animais/etiologia , Camundongos , Camundongos Mutantes , Mutação , Neoplasias Ovarianas/etiologia , Neoplasias Ovarianas/genética , Isoformas de Proteínas , Deleção de SequênciaRESUMO
The Bloom syndrome (BS) protein, BLM, is a member of the RecQ DNA helicase family that also includes the Werner syndrome protein, WRN. Inherited mutations in these proteins are associated with cancer predisposition of these patients. We recently discovered that cells from Werner syndrome patients displayed a deficiency in p53-mediated apoptosis and WRN binds to p53. Here, we report that analogous to WRN, BLM also binds to p53 in vivo and in vitro, and the C-terminal domain of p53 is responsible for the interaction. p53-mediated apoptosis is defective in BS fibroblasts and can be rescued by expression of the normal BLM gene. Moreover, lymphoblastoid cell lines (LCLs) derived from BS donors are resistant to both gamma-radiation and doxorubicin-induced cell killing, and sensitivity can be restored by the stable expression of normal BLM. In contrast, BS cells have a normal Fas-mediated apoptosis, and in response to DNA damage normal accumulation of p53, normal induction of p53 responsive genes, and normal G(1)-S and G(2)-M cell cycle arrest. BLM localizes to nuclear foci referred to as PML nuclear bodies (NBs). Cells from Li-Fraumeni syndrome patients carrying p53 germline mutations and LCLs lacking a functional p53 have a decreased accumulation of BLM in NBs, whereas isogenic lines with functional p53 exhibit normal accumulation. Certain BLM mutants (C1055S or Delta133-237) that have a reduced ability to localize to the NBs when expressed in normal cells can impair the localization of wild type BLM to NBs and block p53-mediated apoptosis, suggesting a dominant-negative effect. Taken together, our results indicate both a novel mechanism of p53 function by which p53 mediates nuclear trafficking of BLM to NBs and the cooperation of p53 and BLM to induce apoptosis.
Assuntos
Adenosina Trifosfatases/química , Adenosina Trifosfatases/metabolismo , Apoptose/fisiologia , Síndrome de Bloom/enzimologia , Ciclo Celular/fisiologia , Dano ao DNA , DNA Helicases/química , DNA Helicases/metabolismo , Proteína Supressora de Tumor p53/química , Proteína Supressora de Tumor p53/metabolismo , Apoptose/efeitos da radiação , Sítios de Ligação , Síndrome de Bloom/genética , Linhagem Celular , Núcleo Celular/fisiologia , Sobrevivência Celular , Relação Dose-Resposta à Radiação , Fibroblastos/citologia , Fibroblastos/fisiologia , Fibroblastos/efeitos da radiação , Técnica Indireta de Fluorescência para Anticorpo , Raios gama , Genes Reporter , Humanos , RecQ Helicases , Proteínas Recombinantes/metabolismo , Valores de Referência , TransfecçãoRESUMO
Cell cycle checkpoints are essential for the maintenance of genomic stability in response to DNA damage. We demonstrated recently that GADD45, a DNA damage-inducible protein, activates a G(2)/M checkpoint induced by either UV radiation or alkylating agents. GADD45 can interact in vivo with the G(2) cell cycle-specific kinase, Cdc2, proliferating cell nuclear antigen (PCNA), and the cell cycle kinase inhibitor p21(waf1). The ability of GADD45 to induce a G(2)/M arrest may be caused in part by the inhibition of Cdc2 kinase activity. Here, we report the identification of a region of GADD45 that is involved in this G(2)/M checkpoint. Mutants of GADD45 that lacked either the first 35 or the last 80 residues still retained an ability to induce G(2)/M arrest. A mutant with a deletion of the central region (residues 50-76), which is conserved in the family members GADD45beta and GADD45gamma, lacked such activity. This mutant also lacked an ability to bind to Cdc2, PCNA, and p21(waf1) in vivo. Consistently, either GADD45beta or GADD45gamma bind to Cdc2 in vivo. However, unlike GADD45, neither GADD45beta nor GADD45gamma inhibited the Cdc2 kinase or induced G(2)/M arrest. The unique effect of GADD45 may be caused by the presence of a region containing DEDDDR residues. Alanine substitutions in the region abolished GADD45 induction of a G(2)/M arrest and its inactivation of the Cdc2 kinase but not its binding to Cdc2, PCNA, or p21(waf1). Therefore, the binding of GADD45 to Cdc2 was insufficient to induce a G(2)/M arrest, and additional activity contributed by the DEDDDR residues may be necessary to regulate the G(2)/M checkpoint.
Assuntos
Fase G2 , Mitose , Proteínas/metabolismo , Sequência de Aminoácidos , Substituição de Aminoácidos , Proteína Quinase CDC2/metabolismo , Quinases relacionadas a CDC2 e CDC28 , Ciclina B/metabolismo , Ciclina B1 , Inibidor de Quinase Dependente de Ciclina p21 , Quinases Ciclina-Dependentes/antagonistas & inibidores , Ciclinas/metabolismo , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Mapeamento de Peptídeos , Mutação Puntual , Antígeno Nuclear de Célula em Proliferação/metabolismo , Proteínas/química , Proteínas/genética , Células Tumorais Cultivadas , Proteínas GADD45RESUMO
Germline mutations of the Brca1 tumor suppressor gene predispose women to breast and ovarian cancers. To study mechanisms underlying BRCA1-related tumorigenesis, we derived mouse embryonic fibroblast cells carrying a targeted deletion of exon 11 of the Brca1 gene. We show that the mutant cells maintain an intact G1-S cell cycle checkpoint and proliferate poorly. However, a defective G2-M checkpoint in these cells is accompanied by extensive chromosomal abnormalities. Mutant fibroblasts contain multiple, functional centrosomes, which lead to unequal chromosome segregation, abnormal nuclear division, and aneuploidy. These data uncover an essential role of BRCA1 in maintaining genetic stability through the regulation of centrosome duplication and the G2-M checkpoint and provide a molecular basis for the role of BRCA1 in tumorigenesis.
Assuntos
Proteína BRCA1/fisiologia , Centrossomo/metabolismo , Aberrações Cromossômicas/genética , Éxons/genética , Fase G2/fisiologia , Genes BRCA1 , Mitose/fisiologia , Isoformas de Proteínas/deficiência , Processamento Alternativo , Aneuploidia , Animais , Proteína BRCA1/deficiência , Proteína BRCA1/genética , Núcleo Celular/metabolismo , Células Cultivadas , Segregação de Cromossomos , Dano ao DNA , Fibroblastos , Marcação In Situ das Extremidades Cortadas , Cariotipagem , Camundongos , Isoformas de Proteínas/genética , Deleção de Sequência , Fuso Acromático/fisiologia , Proteína Supressora de Tumor p53/genética , Proteína Supressora de Tumor p53/fisiologiaRESUMO
This study analyses whether the inability of p53 to induce G1 arrest after the restriction point relates to an inability to modulate pRb phosphorylation. Transient p53 overexpression in normal human diploid fibroblasts and p53-deficient cancer cells led to increased levels of the cyclin-dependent kinase inhibitor p21 cip1/Waf1/Sdi1 and an accumulation of hypophosphorylated pRb in cells growing asynchronously and in cells synchronized in late G1 or M. Similarly, gamma-irradiation of asynchronous, late-G1, or S phase fibroblasts led to an increase in hypophosphorylated pRb. Experiments with fibroblasts expressing the HPV16 E6 protein indicated that accumulation of hypophosphorylated pRb required functional p53. Progression into and through S phase was not altered by the presence of hypophosphorylated pRb in late G1, consistent with the failure of p53 to mediate G1 arrest in cells that are past the restriction point. These data indicate that accumulation of hypophosphorylated pRb has significantly different effects on cell cycle progression in early G1 versus late G1 or S phase.
Assuntos
Ciclo Celular/fisiologia , Quinases Ciclina-Dependentes/antagonistas & inibidores , Ciclinas/biossíntese , Proteína do Retinoblastoma/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Carcinoma Pulmonar de Células não Pequenas , Ciclo Celular/efeitos da radiação , Inibidor de Quinase Dependente de Ciclina p21 , Ciclinas/metabolismo , Diploide , Inibidores Enzimáticos/metabolismo , Fibroblastos , Fase G1 , Raios gama , Humanos , Neoplasias Pulmonares , Proteínas Oncogênicas Virais/biossíntese , Papillomaviridae/genética , Fosforilação , Proteínas Recombinantes/biossíntese , Proteínas Repressoras/biossíntese , Fase S , Células Tumorais Cultivadas , Proteína Supressora de Tumor p53/biossínteseRESUMO
Cell cycle checkpoints are biochemical signal transduction pathways that prevent downstream events from being initiated until upstream processes are completed. We analyzed whether the p53 or pRb tumor suppressors are involved in a checkpoint(s) that prevents DNA rereplication in the presence of drugs that interfere with spindle assembly. Normal mouse and human fibroblasts arrested with a 4N DNA content when treated with nocodazole and Colcemid, whereas isogeneic p53-deficient or pRb-deficient derivatives became polyploid. Flow cytometric and cytogenetic analyses demonstrated that the polyploidy resulted from genome-wide rereplication without an intervening mitosis. Thus, p53 and pRb help maintain normal cell ploidy by preventing DNA rereplication prior to mitotic division.
Assuntos
Ciclo Celular/efeitos dos fármacos , Replicação do DNA/efeitos dos fármacos , Demecolcina/farmacologia , Fibroblastos/efeitos dos fármacos , Nocodazol/farmacologia , Proteína do Retinoblastoma/deficiência , Fuso Acromático/efeitos dos fármacos , Proteína Supressora de Tumor p53/deficiência , Animais , Citometria de Fluxo , Genes do Retinoblastoma , Genes p53 , Humanos , Camundongos , Ploidias , Transdução de Sinais/efeitos dos fármacosRESUMO
A new technique that monitors cell cycle progression over multiple cycles was used to gain insight into how p53 limits the emergence of variants with structural chromosome alterations following gamma-irradiation. G0-synchronized, p53+ (with a functional p53 pathway) normal human fibroblast and epithelial strains underwent a dose-dependent permanent arrest in the initial G0-G1 phase after irradiation. The dose-response curves indicate that a single event, such as an irreparable DNA break, may be sufficient to induce arrest. p53+ cells that escaped the initial G0-G1 phase after irradiation entered S phase in at least two waves. However, many of these cells underwent long-term arrest in subsequent phases. In contrast, virtually all of the cells in isogenic p53- (with a nonfunctional p53 pathway) strains escaped from the first G0-G1 phase without delay, regardless of the dose. p53- cells were also eliminated in subsequent phases but at significantly lower frequencies. Consistent with these findings, the reproductive viability of p53- cells was higher than p53+ cells. The nonclonogenic fraction appeared to be eliminated within three cycles for both cell types. In addition, artificial holding in G0 after irradiation, which allows for the repair of potentially lethal damage, led to similar increases in survival in p53+ and p53- cells. These data are inconsistent with the hypothesis that the primary function of p53-dependent G0-G1 arrest in response to gamma-irradiation is to allow additional time for DNA repair. Rather, they indicate that p53 helps maintain genetic stability by eliminating cells with damaged chromosomes from the reproductively viable population.
Assuntos
Ciclo Celular/genética , Proteína Supressora de Tumor p53/fisiologia , Apoptose/genética , Bromodesoxiuridina/metabolismo , Ciclo Celular/efeitos da radiação , Sobrevivência Celular/genética , Dano ao DNA , Reparo do DNA , Células Epiteliais , Epitélio/efeitos da radiação , Fibroblastos/citologia , Fibroblastos/efeitos da radiação , Raios gama , Genes p53RESUMO
TP53 serves as a key relay for signals elicited by cellular stresses arising from diverse environmental or therapeutic insults. This relay then activates a cell cycle arrest or cell death program, depending on the stimulus and cell type. The absence of TP53 function disables the cell death or arrest programmes, thereby allowing the emergence of variants with various types of genomic alterations. The data discussed focus on two different types of signals that trigger the TP53 relay system. Firstly, TP53 arrests cell cycle progression in response to the types of DNA damage most commonly detected in cells undergoing tumour progression. Secondly, TP53 is activated by specific depletion of ribonucleotide pools, which prevent cells from entering S phase under conditions that could lead to chromosome breakage. The contribution of both responses limits the emergence of genetic variants. The DNA damage induced arrest appears to be triggered by as few as one double strand break in normal human fibroblasts. Analysis of the arrest kinetics after ionizing radiation shows that TP53 activates a prolonged arrest response in cells with irreparable DNA damage and that high efficiency cell elimination is achieved by a process that can be activated over multiple cell cycles. These data indicate that the primary function of the TP53 arrest/apoptosis pathway in response to double strand break is to eliminate damaged cells from the proliferating population, not to allow additional time for lesion repair. However, it remains possible that repair of other types of damage may benefit from TP53 mediated arrest. Analyses in model genetic systems indicate that the absence of TP53 function allows, but does not ensure, a high intrinsic rate of genetic variation and that instability is increased substantially when cells proceed through S phase under inappropriate growth conditions. This implies that inactivation of TP53 function in combination with other genetic alterations, such as oncogene activation, could accelerate genomic instability and tumour progression.
Assuntos
Dano ao DNA , Fase G1/genética , Genes p53/genética , Neoplasias/genética , Fase de Repouso do Ciclo Celular/genética , Transdução de Sinais/genética , Proteína Supressora de Tumor p53/biossíntese , Fibroblastos/fisiologia , Fase G1/fisiologia , Regulação da Expressão Gênica , Genes p53/fisiologia , Genes p53/efeitos da radiação , Humanos , Fase de Repouso do Ciclo Celular/fisiologia , Proteína Supressora de Tumor p53/metabolismoRESUMO
The Mdm2 oncoprotein forms a complex with the p53 tumor suppressor protein and inhibits p53-mediated regulation of heterologous gene expression. Recently, Mdm2 has been found to bind several other proteins that function to regulate cell cycle progression, including the E2F-1/DP1 transcription factor complex and the retinoblastoma tumor-suppressor protein. To determine whether Mdm2 plays a role in cell cycle control or tumorigenesis that is distinct from its ability to modulate p53 function, we have examined and compared both the in vitro growth characteristics of p53-deficient and Mdm2/p53-deficient fibroblasts, and the rate and spectrum of tumor formation in p53-deficient and Mdm2/p53-deficient mice. We find no difference between p53-deficient fibroblasts and Mdm2/p53-deficient fibroblasts either in their rate of proliferation in culture or in their survival frequency when treated with various genotoxic agents. Cell cycle studies indicate no difference in the ability of the two cell populations to enter S phase when treated with DNA-damaging agents or nucleotide antimetabolites, and p53-deficient fibroblasts and Mdm2/p53-deficient fibroblasts exhibit the same rate of spontaneous immortalization following long-term passage in culture. Finally, p53-deficient mice and Mdm2/p53-deficient mice display the same incidence and spectrum of spontaneous tumor formation in vivo. These results demonstrate that deletion of Mdm2 has no additional effect on cell proliferation, cell cycle control, or tumorigenesis when p53 is absent.
Assuntos
Ciclo Celular , Transformação Celular Neoplásica , Neoplasias Experimentais/genética , Proteínas Nucleares , Proteínas Proto-Oncogênicas/deficiência , Proteína Supressora de Tumor p53/deficiência , Animais , Divisão Celular/efeitos dos fármacos , Divisão Celular/efeitos da radiação , Células Cultivadas , Cruzamentos Genéticos , Embrião de Mamíferos , Fibroblastos/citologia , Regulação da Expressão Gênica , Genótipo , Heterozigoto , Camundongos , Camundongos Knockout , Mitomicina/farmacologia , Proteínas de Neoplasias/biossíntese , Neoplasias Experimentais/fisiopatologia , Proteínas Proto-Oncogênicas/biossíntese , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-mdm2 , Proteína Supressora de Tumor p53/biossíntese , Proteína Supressora de Tumor p53/genética , Raios UltravioletaRESUMO
Cells with a functional p53 pathway undergo a G0/G1 arrest or apoptosis when treated with gamma radiation or many chemotherapeutic drugs. It has been proposed that DNA damage is the exclusive signal that triggers the arrest response. However, we found that certain ribonucleotide biosynthesis inhibitors caused a p53-dependent G0 or early G1 arrest in the absence of replicative DNA synthesis or detectable DNA damage in normal human fibroblasts. CTP, GTP, or UTP depletion alone was sufficient to induce arrest. In contrast to the p53-dependent response to DNA damage, characterized by long-term arrest and irregular cellular morphologies, the antimetabolite-induced arrest was highly reversible and cellular morphologies remained relatively normal. Both arrest responses correlated with prolonged induction of p53 and the Cdk inhibitor P21(WAF1/CIP1/SDI1) and with dephosphorylation of pRb. Thus, we propose that p53 can serve as a metabolite sensor activated by depletion of ribonucleotides or products or processes dependent on ribonucleotides. Accordingly, p53 may play a role in inducing a quiescence-like arrest state in response to nutrient challenge and a senescence-like arrest state in response to DNA damage. These results have important implications for the mechanisms by which p53 prevents the emergence of genetic variants and for developing more effective approaches to chemotherapy based on genotype.
Assuntos
Antimetabólitos Antineoplásicos/farmacologia , Ciclo Celular , Ribonucleotídeos/metabolismo , Proteína Supressora de Tumor p53/fisiologia , Monofosfato de Adenosina/metabolismo , Amidas , Ácido Aspártico/análogos & derivados , Ácido Aspártico/farmacologia , Ciclo Celular/efeitos dos fármacos , Células Cultivadas , Aberrações Cromossômicas , Dano ao DNA , Raios gama , Humanos , Masculino , Ácido Fosfonoacéticos/análogos & derivados , Ácido Fosfonoacéticos/farmacologia , Pirazóis , RNA/biossíntese , Ribonucleosídeos/farmacologia , RiboseRESUMO
The stability of the mammalian genome depends on the proper function of G1 and G2 cell cycle control mechanisms. Two tumor suppressors, p53 and retinoblastoma (Rb), play key roles in progression from G1 into S-phase. We address the mechanisms by which these proteins mediate a G1 arrest in response to DNA damage and limiting metabolic conditions. Gamma-irradiation induced a prolonged, p53-dependent G1 arrest associated with a long-term increase in the levels of the cdk-inhibitor p21WAFl/Cipl (p21). Microinjection of linear plasmid DNA also caused a G1 arrest. The p53-dependent arrest induced by inhibitors of UMP biosynthesis was reversible and occurred in the absence of detectable DNA damage. Both arrest mechanisms contribute to limiting the formation and propagation of damaged genomes. Cells containing mutant p53 but wild-type Rb do not generate methotrexate (Mtx) resistant variants. However, pre-treatment with DNA damaging agents prior to drug selection resulted in resistant clones containing amplified dihydrofolate reductase (DHFR) genes, suggesting that DNA breakage is a rate limiting step for gene amplification. The Mtx-induced arrest did not occur in cells with non-functional Rb. Rb acts as a negative regulator of the E2F transcription factors, and Rb-deficient primary mouse embryo fibroblasts (MEFs) produced elevated levels of mRNA and protein for key E2F target genes. Failure to prevent entry into S-phase in Rb-/- MEFs exposed to DNA-damaging or nutrient limiting conditions caused apoptosis and correlated with p53 induction. Taken together, these findings indicate a link between p53 and Rb function and suggest that their coordination insures correct entry into S-phase, minimizing the emergence of genetic variants.
Assuntos
Genoma , Mutação , Neoplasias/genética , Fase S/genética , Animais , Antimetabólitos/farmacologia , Apoptose/genética , Transformação Celular Neoplásica/efeitos dos fármacos , Transformação Celular Neoplásica/genética , Aberrações Cromossômicas , Inibidor de Quinase Dependente de Ciclina p21 , Ciclinas/biossíntese , Ciclinas/genética , Dano ao DNA/genética , Dano ao DNA/fisiologia , Fase G1/genética , Fase G1/efeitos da radiação , Regulação da Expressão Gênica/efeitos dos fármacos , Genes do Retinoblastoma , Genes p53 , Humanos , Fator 2 de Elongação de Peptídeos , Fatores de Alongamento de Peptídeos/biossíntese , Fatores de Alongamento de Peptídeos/genética , Inibidores de Proteínas Quinases , Proteínas Quinases/biossíntese , Proteínas Quinases/genética , Proteína do Retinoblastoma/biossíntese , Proteína do Retinoblastoma/deficiência , Proteína do Retinoblastoma/genética , Fase S/efeitos dos fármacos , Proteína Supressora de Tumor p53/biossíntese , Proteína Supressora de Tumor p53/genéticaRESUMO
The tumor suppressor p53 is a cell cycle checkpoint protein that contributes to the preservation of genetic stability by mediating either a G1 arrest or apoptosis in response to DNA damage. Recent reports suggest that p53 causes growth arrest through transcriptional activation of the cyclin-dependent kinase (Cdk)-inhibitor Cip1. Here, we characterize the p53-dependent G1 arrest in several normal human diploid fibroblast (NDF) strains and p53-deficient cell lines treated with 0.1-6 Gy gamma radiation. DNA damage and cell cycle progression analyses showed that NDF entered a prolonged arrest state resembling senescence, even at low doses of radiation. This contrasts with the view that p53 ensures genetic stability by inducing a transient arrest to enable repair of DNA damage, as reported for some myeloid leukemia lines. Gamma radiation administered in early to mid-, but not late, G1 induced the arrest, suggesting that the p53 checkpoint is only active in G1 until cells commit to enter S phase at the G1 restriction point. A log-linear plot of the fraction of irradiated G0 cells able to enter S phase as a function of dose is consistent with single-hit kinetics. Cytogenetic analyses combined with radiation dosage data indicate that only one or a small number of unrepaired DNA breaks may be sufficient to cause arrest. The arrest also correlated with long-term elevations of p53 protein, Cip1 mRNA, and Cip1 protein. We propose that p53 helps maintain genetic stability in NDF by mediating a permanent cell cycle arrest through long-term induction of Cip1 when low amounts of unrepaired DNA damage are present in G1 before the restriction point.